HL7 FHIR Implementation Guide: Common Terminology Criteria (CTC) Adverse Events Release 1 - DRAFT
0.0.1 - DRAFT United States of America flag

HL7 FHIR Implementation Guide: Common Terminology Criteria (CTC) Adverse Events Release 1 - DRAFT, published by HL7 International Clinical Interoperability Council. This guide is not an authorized publication; it is the continuous build for version 0.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/standardhealth/fsh-ae/ and changes regularly. See the Directory of published versions

: Adverse Event Seriousness Value Set - XML Representation

Draft as of 2024-02-28

Raw xml | Download



<ValueSet xmlns="http://hl7.org/fhir">
  <id value="adverse-event-seriousness-value-set"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><ul><li>Include these codes as defined in <a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-nciThesaurus.html"><code>http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>C41335</td><td>Serious Adverse Event</td></tr><tr><td>C41336</td><td>Non-serious Adverse Event</td></tr></table></li></ul></div>
  </text>
  <url
       value="http://hl7.org/fhir/us/ctcae/ValueSet/adverse-event-seriousness-value-set"/>
  <version value="0.0.1"/>
  <name value="AdverseEventSeriousnessVS"/>
  <title value="Adverse Event Seriousness Value Set"/>
  <status value="draft"/>
  <date value="2024-02-28T19:15:22+00:00"/>
  <publisher value="HL7 International Clinical Interoperability Council"/>
  <contact>
    <name value="HL7 International Clinical Interoperability Council"/>
    <telecom>
      <system value="url"/>
      <value value="http://www.mcodeinitiative.org"/>
    </telecom>
  </contact>
  <description
               value="An adverse event is classified as serious or non-serious. It is considered serious if it results in any of the following outcomes: (1) Death, (2) Life-threatening experience, 3) Inpatient hospitalization or prolongation of existing hospitalization (for &gt; 24 hours), (4) Persistent or significant incapacity or substantial disruption of the ability to conduct normal life functions, (5) Congenital anomaly/birth defect, or (6) Important Medical Event (IME) that may jeopardize the patient or subject and may require medical or surgical intervention to prevent one of the outcomes listed in this definition (reference: https://crawb.crab.org/txwb/CRA_MANUAL/Vol1/chapter%2013_Serious%20Adverse%20Events.pdf)."/>
  <jurisdiction>
    <coding>
      <system value="urn:iso:std:iso:3166"/>
      <code value="US"/>
      <display value="United States of America"/>
    </coding>
  </jurisdiction>
  <compose>
    <include>
      <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"/>
      <concept>
        <code value="C41335"/>
        <display value="Serious Adverse Event"/>
      </concept>
      <concept>
        <code value="C41336"/>
        <display value="Non-serious Adverse Event"/>
      </concept>
    </include>
  </compose>
</ValueSet>